182 related articles for article (PubMed ID: 7865194)
1. Towards more effective antipsychotic treatment.
Kane JM; Freeman HL
Br J Psychiatry Suppl; 1994 Nov; (25):22-31. PubMed ID: 7865194
[TBL] [Abstract][Full Text] [Related]
2. [New chemotherapy approaches to psychoses].
Olié JP; Baylé FJ
Encephale; 1997 Apr; 23 Spec No 2():2-9. PubMed ID: 9273302
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy of schizophrenia: a review.
Sigmundson HK
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S70-5. PubMed ID: 7533053
[TBL] [Abstract][Full Text] [Related]
4. Atypical antipsychotics: mechanism of action.
Seeman P
Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
[TBL] [Abstract][Full Text] [Related]
5. Novel versus conventional antipsychotic drugs.
Love RC
Pharmacotherapy; 1996; 16(1 Pt 2):6-10. PubMed ID: 8778684
[TBL] [Abstract][Full Text] [Related]
6. Novel pharmacological approaches to the treatment of schizophrenia.
Fink-Jensen A
Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
[TBL] [Abstract][Full Text] [Related]
7. [Atypical pharmacologic characteristics of an antipsychotic drug: clozapine].
Gosselin O; Ribeyre JM; Kahn JP
Encephale; 1997 Sep; 23 Spec No 4():2-6. PubMed ID: 9417400
[TBL] [Abstract][Full Text] [Related]
8. Conventional versus novel antipsychotics: changing concepts and clinical implications.
Remington G; Chong SA
J Psychiatry Neurosci; 1999 Nov; 24(5):431-41. PubMed ID: 10586534
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of clozapine versus other antipsychotics on clinical outcome and dopamine release in the brain.
Advokat C
Essent Psychopharmacol; 2005; 6(2):73-90. PubMed ID: 15765792
[TBL] [Abstract][Full Text] [Related]
10. Serotonin receptors: their key role in drugs to treat schizophrenia.
Meltzer HY; Li Z; Kaneda Y; Ichikawa J
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1159-72. PubMed ID: 14642974
[TBL] [Abstract][Full Text] [Related]
11. [Clozapine and treatment of negative symptoms].
Lançon C; Farisse J; Llorca PM
Encephale; 1997 Sep; 23 Spec No 4():7-11. PubMed ID: 9417403
[TBL] [Abstract][Full Text] [Related]
12. [Clinical psychopharmacology: the example of clozapine (Leponex)].
Péré JJ
Encephale; 1995 Jun; 21 Spec No 3():9-12. PubMed ID: 7628347
[TBL] [Abstract][Full Text] [Related]
13. Optimizing clozapine treatment.
Naber D
J Clin Psychiatry; 1999; 60 Suppl 12():35-8. PubMed ID: 10372609
[TBL] [Abstract][Full Text] [Related]
14. New drugs for the treatment of schizophrenia.
Meltzer HY
Psychiatr Clin North Am; 1993 Jun; 16(2):365-85. PubMed ID: 8101373
[TBL] [Abstract][Full Text] [Related]
15. [Current data on neurologic sequelae caused by neuroleptics].
Krebs MO
Encephale; 1995 Jun; 21 Spec No 3():49-52. PubMed ID: 7628342
[TBL] [Abstract][Full Text] [Related]
16. Management of treatment-resistant patients with schizophrenia.
Marder SR
J Clin Psychiatry; 1996; 57 Suppl 11():26-30. PubMed ID: 8941168
[TBL] [Abstract][Full Text] [Related]
17. Improving the treatment of schizophrenia: focus on serotonin (5-HT)(1A) receptors.
Millan MJ
J Pharmacol Exp Ther; 2000 Dec; 295(3):853-61. PubMed ID: 11082417
[TBL] [Abstract][Full Text] [Related]
18. [Creativity and antipsychotic drugs].
Murry P; Torrecuadrada JL
Encephale; 1997 Sep; 23 Spec No 4():17-9. PubMed ID: 9417399
[TBL] [Abstract][Full Text] [Related]
19. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.
Meltzer HY; Huang M
Prog Brain Res; 2008; 172():177-97. PubMed ID: 18772033
[TBL] [Abstract][Full Text] [Related]
20. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis.
Kuroki T; Nagao N; Nakahara T
Prog Brain Res; 2008; 172():199-212. PubMed ID: 18772034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]